- Country: Jordan
- Summary: HLA Reagents & Luminex
- JOT Ref No: 65670397
- Deadline: 19 May 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: P37-2022-35
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tenders are invited for HLA Reagents & Luminex. Ficoli Hypaque, Ready to Use for Separation of Lymphocytes . (100 Ml/Bott), Rpmi 1640 Medium, with Glutamine, Sterile in 500ml Bottles, Rabbit 3mi Vial. Low Cytotoxicity Suitable for Histocompatibiiity Testing, Bla Dqai or Dqbi or Dqaibi Ssp by Pcr Gel Detection or Lab Type Sso Hiaa Dqai Dqbi or Dqaibi Reagent for Sso Dna Typing for Luminex (Xmap Technology) High Resolution Kit or Any Other Approved Methods. starting date 2022-04-20 closing date 2022-05-19 Extension date 2022-05-19 price (d) 75 JOD [Disclaimer: The above text is machine translated. For accurate information kindly refer the original document.]
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINHLA Reagents & Luminex - Jordan Tender
The JORDANIAN ROYAL MEDICAL SERVICES, a Government sector organization in Jordan, has announced a new tender for HLA Reagents & Luminex. This tender is published on JordanTenders under JOT Ref No: 65670397 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-05-19.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
